MNS blood group in Thai population: significant or not ?
Keywords:
-Abstract
-
Downloads
References
Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen: Facts Book. 3rd ed. Boston: Academic Press; 2012.
Lublin DM. Functional roles of blood group antigens. In: Silberstein LE, editor. Molecular and unctional aspects of blood group antigens. Geneva: American Association of Blood Banks; 1995. p. 163-92.
Allaway GP, Burness AT. Site of attachment of encephalomyocarditis virus on human erythrocytes. J Virol. 1986;59:768-70.
Lomas-Francis C. Miltenberger phenotypes are glycophorin variants: a review. VOXS. 2011;6:296-301.
Palacajornsuk P. Review: molecular basis of MNS blood group variants. Immunohematology. 2006;22:171-82.
http://www.isbtweb.org. The International Society of Blood Transfusion. Red cell immunogenetics and blood group terminology working party; 2021.
Palacajornsuk P, Nathalang O, Tantimavanich S, Bejrachandra S, Reid M. Detection of MNS hybrid molecules in the Thai population using PCR-SSP technique. Transfusion Med (Oxford, England). 2007;17:169-74.
Kaset C, Nathalang S, Leetrakool L, Nathalang O. Detection of MNS hybrid molecules (GP.Hut, GP.Mur, GP.Hop, GP.Bun and GP.HF) in central and northern Thai blood donors. J Hematol Transfus Med. 2015;25:101-6.
Lopez GH, Wilson B, Liew YW, Kupatawintu P, Emthip M, Hyland CA, et al. An alloantibody in a homozygous GYP*Mur individual defines JENU (MNS49), a new high-frequency antigen on glycophorin B. Transfusion. 2017;57:716-7.
Storry JR, Reid ME, MacLennan S, Lubenko A, Nortman P. The low-incidence MNS antigens M(v), s(D), and Mit arise from single amino acid substitutions on GPB. Transfusion. 2001;41:269-75.
Furuhjelm U, Myllyla G, Nevanlinna HR, Nordling S, Pirkola A, Gavin J, et al. The red cell phenotype En(a-) and anti-Ena: serological and physio-chemical aspects. Vox Sang. 1969;17:256-78.
Thongbai R, Sasijit V, Phinyada R, Waraporn P, Viroje C. Red cell phenotyping in blood donors to provide safe blood transfusion for transfused patients at Siriraj Hospital. J Hematol Transfus Med. 2018;28:423-30.
Pasuporn P, Sutida S, Kanjanaporn C, Kullanit P. The Prevalence of red blood cell alloantibodies in lower northern Thailand. J Med Assoc Thai. 2016;99:1337-43.
Pawinee K, Morakot E, Duangporn S, Phuraya O, Vimol M, Sudawon L, et al. Unexpectedantibodies of patients, blood samples sent for testing at NBC, TRCS. J Hematol Transfus Med. 2010;20:255-62
Chiewsilp O, Yodpornpin W, Cherdchai S. Delayed hemolytic transfusion reaction due to anti-Mia. Thai J Hemato Transfu Med. 1996;6:289-90.
Emthip M SA, Patrungsi Y, Suwanwootichai P, Kupatawintu P.Anti-Hop, a rare antibody of Miltenberger subclass in a Thai patient: a case report. J Hematol Transfus Med. 2014;24:41-5.
Janthaaksorn J, Kupatawintu P, Nathalang O, Charoonruangrit U, Bejrachandra S. Identification of a rare alloanti-GP.Hil (anti-MNS20) in a Thai patient: a case report. J Hematol Transfus Med. 2016;26:373-8.
Hassan SN, Thirumulu Ponnuraj K, Mohamad S, Hassan R, Wan Ab Rahman WS. Molecular detection of glycophorins A and B variant phenotypes and their clinical relevance. Transfus Med Rev. 2019;33:118-24.
Shapiro M, Le Roux ME. Serology and genetics of a 'new' red cell antigen: sD. Transfusion. 1981;21 :614. (abstract).
Poole J, Grimsley S, Ligthart P, de Haas M, de Vooght K, Bullock T, et al. A novel RhAG blood group antigen associated with severe HDFN. Vox Sang. 2011;101 (Suppl. 1):70.
D-S24-02 Abstract].
Storry JR, Clausen FB, Castilho L, Chen O, Daniels G, Denomme G, et al. International Society of Blood Transfusion working party on red cell immunogenetics and blood group terminology: report of the Dubai, Copenhagen and Toronto meetings. Vox Sang. 2019;114:95-102.
Dahr W, Moulds JJ. High-frequency antigens of human erythrocyte membrane sialoglycoproteins, IV. Molecular properties of the U antigen. Biol Chem Hoppe Seyler. 1987;368:659–67.
Ballas SK, Reilly PA, Murphy DL. The blood group U antigen is not located on glycophorin B. Biochim Biophys Acta. 1986;884:337-43.
Novaretti MC, Jens E, Pagliarini T, Bonif cio Sle O, Dorlhiac-Llacer PE, Chamone Dd Dde A. Hemolytic disease of the newborn due to anti-U. Rev Hosp Clin Fac Med Sao Paulo. 2003;58:320-3.
Furuhjelm U, Myllylä G, Nevanlinna HR, Nordling S, Pirkola A, Gavin J, et al. The red cell phenotype En(a-)and anti-Ena: serological and physicochemical aspects. Vox Sang. 1969;17:256-78.
Furuhjelm U, Nevanlinna HR, Pirkola A. A second Finnish En(a-) propositus with anti-Ena. Vox Sang. 1973;24:545-9.
Howard P, Guerra L, Kuttner DK, George MR. Clinical approach after identification of a rare anti-Ena in a prenatal sample. Immunohematology. 2019;35:159-61.
Walker PS, Bergren MO, Busch MP, Carmody AM, Perkins HA. Finnish En(a-) propositus with anti-EnaFS and anti-EnaFR: in vitro and in vivo characteristics. Vox Sang. 1987;52:103-6.
Okubo Y, Seno T, Yamaguchi H, Miyata Y, Green CA, Daniels GL. En(a-) phenotype in a Japanese blood donor. Immunohematology. 1993;9:105-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Hematology and Transfusion Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
